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Abstract
Background: Older paternal age may increase the germ cell mutation rate in the offspring.
Maternal age may also mediate in utero exposure to pregnancy hormones in the offspring. To
evaluate the association between paternal and maternal age at birth with the risk of breast cancer
in female offspring, a case-control study was conducted in Korea.
Methods: Histologically confirmed breast cancer cases (n = 1,011) and controls (n = 1,011) with
no present or previous history of cancer, matched on year of birth and menopausal status, were
selected from several teaching hospitals and community in Seoul during 1995–2003. Information on
paternal and maternal ages and other factors was collected by interviewed questionnaire. Odds
ratio (OR) and 95% confidence interval (95% CI) were estimated by unconditional logistic
regression model adjusting for family history of breast cancer in 1st or 2nd degree relatives, and
lifetime estrogen exposure duration.
Results: The risk of breast cancer significantly increased as the paternal age increased (p for trend
= 0.025). The association was stronger after controlling for maternal age; women whose fathers
were aged ≥40 years at their birth had 1.6-fold increased risk of breast cancer compared with
fathers aged <30 years. This association was profound in breast cancer cases in premenopausal
women (OR = 1.9, 95% CI = 1.12–3.26, for paternal aged ≥40 vs. <30) (p for trend = 0.031).
Although the risk of breast cancer increased as maternal age increased up to the intermediate, and
then reduced; the risks in women whose mother were aged 25–29, 30–34, and ≥35 yrs at birth
compared to women whose mothers were aged <25 years, were 1.2, 1.4, and 0.8, respectively, the
trend was not significant (p for trend = 0.998).
Conclusion: These findings suggest that older paternal age increases the risk of breast cancer in
their female offspring.
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Background
There have been growing evidences that prenatal factors
may play an important role in determining breast cancer
risk in adult life. These factors are hypothesized to affect
breast cancer risk by altering the hormonal environment
of the developing fetus [1], or by affecting the cumulative
frequency of germ cell mutations [2,3].
A numbers of epidemiologic research have suggested that
older parental ages may influence risk for subsequent
development of breast cancer later in their lives. Several
studies found a slightly increased risk of breast cancer for
women whose mothers were older [4-11], but not all [12-
25]. Similarly, there have been conflicting results with
regard to breast cancer risk according to paternal age
[4,5,8,9,13,16,18,20,24,25]. Recently, Innes et al [7] sug-
gested that there was a positive trend in risk of breast can-
cer with increasing paternal age in young women.
These inconsistent results from previous studies might be
due to several factors; small numbers of breast cancer
cases, subject selection (e.g., age at diagnosis, different
ethnicity), improper adjustment of covariates and pater-
nal and maternal ages mutually, other study design issue
(no information on known risk factors).
There is a trend toward higher paternal and maternal ages
predominantly in Korea as well as in developed countries
[26]. To our knowledge no studies published to date have
specifically addressed the association between paternal
and maternal ages and breast cancer risk in Asian women.
We evaluate the independent effect of both paternal and
maternal ages at birth on the risk of breast cancer of their
daughters in a large case-control study in Korean.
Methods
The cases consisted of a consecutive series of breast cancer
patients admitted to three teaching hospitals located in
Seoul, Korea (SNUH, Borame, and Asan) between 1995
and 2003. The control subjects consisted of non-cancer
patients admitted to the same hospitals as the cases in the
same period and of healthy women who participated in
the community health screening program provided by a
teaching hospital located in Seoul (EWUMC) in 2003. The
study design was approved by the Institutional Review
Board of Seoul National University Hospital, and the sub-
jects provided their informed consents prior to participa-
tion in the study.
Of 1,999 histologically confirmed incident breast cancer
patients and 1,548 cancer-free controls, 1,709 breast can-
cer cases and 1,412 cancer-free controls were eligible after
exclusion of subjects with previous history of cancer or
previous history of hysterectomy and/or oophorectomy
due to cervical, ovarian cancer or its precursors. The con-
trol group consisted of 577 healthy women and of 835
hospital controls with non-cancerous diseases including
infection or stone of gall bladder/bile duct (26%), benign
breast disease (e.g. fibroadenomas, fibrocystic disease,
mastitis, etc.) (17%), acute appendicitis (14%), hemor-
rhoid (8%), hernia/perforation (7%), lipoma (2%), and
the others (26% included liver injury, cellulitis, chronic
bowl disease, benign vascular disease, ulcer, etc.). The
proportion of atypical hyperplasia was estimated less than
0.2% among benign breast disease in Korean [27].
Information on demographic characteristics, current and
previous residence, education, marital status, family his-
tory of breast cancer in the 1st and 2nd degree relatives,
reproductive and menstrual factors, life-style habits
including cigarette smoking, alcohol consumption, oral
contraceptive use, and hormone replacement therapy was
collected by trained interviewers using a structured ques-
tionnaire.
After exclusion of subjects with missing value of either
maternal or paternal age (n = 185 in cases; n = 320 in con-
trols), cases were frequency matched to controls by 10-
year of birth group (before 1930, 1930–1939, 1940–
1949, 1950–1959, 1960–1969, after 1970) and meno-
pausal status. The final study population consisted of
1,011 cases and 1,011 controls. The distribution of
matched controls was similar to that of unmatched con-
trols (missing either paternal or maternal age) with regard
to age, family history of breast cancer in 1st or 2nd degree
relatives, and lifetime estrogen exposure duration. Risk
factors profiles were not different between hospital and
healthy community controls [28]; although community
controls were older than hospital controls, the distribu-
tions of most known risk factors (e.g., education, family
history of breast cancer in 1st and 2nd degree relatives) were
similar. The means of paternal and maternal ages at birth
were not significantly different between hospital and
community controls (32.7 vs. 32.1 in paternal age, p =
0.222; 28.3 vs. 28.4 in maternal age, p = 0.807 examined
by t-test). The means of paternal and maternal age at birth
of patients with benign breast disease among controls
were also different from neither hospital controls nor
overall controls (data not shown). Although eighty-seven
percent of hospital controls and 97% of community con-
trols came from the same catchment areas (Seoul and sub-
urbs), other demographical characteristics (e.g., age,
paternal age, maternal age) were similar between hospital
and community controls. Thus, the final statistical analy-
ses were done by adjusting for all significant covariates
identified from the initial analysis.
The associations between factors of interest and breast
cancer risk were estimated as odds ratios (ORs) and 95%
confidence intervals (CIs) by unconditional logisticBMC Cancer 2005, 5:143 http://www.biomedcentral.com/1471-2407/5/143
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regression model adjusting for family history of breast
cancer in 1st or 2nd degree relatives (yes/no), and lifetime
estrogen exposure duration (yrs) (presenting the number
of years of exposure to menstrual cycles, which is calcu-
lated according to the age at menarche and age at inter-
view for premenopausal women and age at menarche and
age at menopause for postmenopausal women), which
were identified as the significant covariates (p value <
0.05) in the initial analysis. The variables included in the
logistic model were selected among age (yrs), education
(under or at middle school, at high school, at or over col-
lege), family history of breast cancer in 1st or 2nd degree
relatives (yes/no), lifetime estrogen exposure duration
(yrs), age at full-term pregnancy or nulliparous (<25 yrs,
25–29 yrs, ≥30 yrs or nulliparity), cigarette smoking
(smoked at least 400 cigarettes/lifetime, yes/no), fre-
quency of alcohol consumption (<1/month, 1–3/month,
≥1/week) and body mass index (BMI) (<25.0 kg/m2,
25.0–30.0 kg/m2, ≥30.0 kg/m2). Only the adjusted esti-
mates were reported in the results because the change in
the β coefficient for any level of the paternal and maternal
ages relative to the referent was less than 20% between
unadjusted estimates and those adjusted for family his-
tory of breast cancer in 1st or 2nd degree relatives (yes/no),
and lifetime estrogen exposure duration (yrs). Tests for
trend in risk were conducted by treating categorical values
as a continuous variable.
Paternal and maternal ages of subjects at birth were first
compared using t-test and the estimates of odds ratios
(ORs) with adjustment for other covariates were obtained
using unconditional logistic regression analysis. We clas-
sified subjects into four groups according to paternal age
at birth (<30, 30–34, 35–39, ≥40) and maternal age at
birth (<25, 25–29, 30–34, ≥35). Separate analysis was
conducted with and without the other paternal or mater-
nal age mutually adjusting. To evaluate the independent
effect of paternal and maternal ages, the ORs were calcu-
lated after stratified by the each paternal and maternal age
group. Finally, we assessed the association of paternal and
maternal ages at birth with breast cancer after stratified by
menopausal status. All statistical analyses were performed
using STATA version 8.0 (Stata corporation, College Sta-
tion, TX).
Results
Family history of breast cancer in 1st and 2nd degree rela-
tives (OR = 2.2, 95% CI = 1.47–3.38), lifetime estrogen
Table 1: Selected characteristics for 1,011 breast cancer cases and 1,011 controls matched by year of birth and menopausal status
Risk factor Cases (%) Control (%) OR (95% CI)
n = 1,011 n = 1,011
Age (yrs) (mean ± SD) 47.7 ± 10.9 47.7 ± 11.7 p = 0.984*
Education
Under or at middle school 315 (31.3) 319 (31.7) 1.0
At high school 378 (37.5) 407 (40.5) 1.0 (0.80–1.24)
At or over college 315 (31.3) 280 (27.8) 1.2 (0.98–1.57)
FHBC‡
No 937 (92.7) 976 (96.5) 1.0
Yes 74 (7.3) 35 (3.5) 2.2 (1.47–3.38)
Age at FFTP‡ (yrs) or nulliparity
<25 325 (32.2) 349 (34.9) 1.0
25–29 477 (47.3) 471 (47.1) 1.1 (0.92–1.38)
≥30 or nulliparity 206 (20.4) 181 (18.1) 1.3 (1.04–1.76)
P for trend p = 0.027
LEE‡ (yrs) (mean ± SD) 29.1 ± 6.9 28.3 ± 7.4 1.2 (1.05–1.41)†
BMI (kg/m2)
<25.0 748 (74.4) 769 (76.8) 1.0
25.0–29.9 227 (22.6) 216 (21.6) 1.0 (0.84–1.29)
≥30.0 31 (3.1) 16 (1.6) 2.0 (1.07–3.78)
Smoking status
Nonsmoker 933 (92.4) 943 (93.4) 1.0
Smoker 77 (7.6) 67 (6.6) 1.2 (0.85–1.70)
Alcohol drinking
<1/month 756 (74.8) 709 (72.3) 1.0
1–3/month 178 (17.6) 211 (21.5) 0.8 (0.64–1.02)
≥1/week 77 (7.6) 61 (6.2) 1.2 (0.86–1.76)
OR of case vs. matched control adjusted for family history of breast cancer in 1st or 2nd degree relatives and lifetime estrogen exposure duration
*P value by student t test, †OR per 10 year, ‡FHBC, Family history of breast cancer in 1st or 2nd degree relatives; FFTP, first full-term pregnancy; LEE, 
lifetime estrogen exposure durationBMC Cancer 2005, 5:143 http://www.biomedcentral.com/1471-2407/5/143
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exposure duration (per 10 years) (OR = 1.2, 95% CI =
1.05–1.41), ≥30 age at first full-term pregnancy or nulli-
parity (OR = 1.3, 95% CI = 1.04–1.76) and BMI ≥30 kg/
m2 (OR = 2.0, 95% CI = 1.07–3.78) increased the risk of
breast cancer significantly after adjusting for family his-
tory of breast cancer in 1st and 2nd degree relatives, and
lifetime estrogen exposure duration (Table 1).
The mean of paternal age at birth was significantly differ-
ent between cases and controls (33.1 yrs vs. 32.5 yrs; OR
= 1.1, 95% CI = 1.00–1.28 per 10 yrs), however, the mean
of maternal age was not (28.7 yrs vs. 28.3 yrs; OR = 1.1,
95% CI = 0.97–1.28 per 10 yrs) (Table 2). The risk of
breast cancer showed a significantly increased as paternal
age at birth increased (p for trend = 0.025). The associa-
tion of paternal age with the risk of breast cancer was pro-
nounced after controlling for maternal age; women whose
fathers were aged 30–34, 35–39, and ≥40 yrs at their
births, had 1.0, 1.0, and 1.6-fold increased risk of breast
cancer compared with women whose fathers were aged
<30 years, respectively. The risk of breast cancer increased
as maternal age increased up to the intermediate, and then
reduced; the risks in women whose mother were aged 25–
29, 30–34, and ≥35 yrs at birth compared to women
whose mothers were aged <25 years, were 1.2, 1.4, and
0.8, respectively (Table 2). The most remarkable risk of
breast cancer was observed for women with higher pater-
nal age (≥40 yrs) and intermediate maternal age (30–34
yrs) compared to women with lowest paternal (<30 yrs)
and maternal ages (<25 yrs) (OR = 2.8, 95% CI = 1.74–
4.62) (Table 3).
When the association was evaluated after stratified by
menopausal status, the association of paternal age at birth
in breast cancer was stronger in premenopausal women.
Women whose fathers were aged 30–34, 35–39 and ≥40
years at their birth had 1.1, 1.2 and 1.9-fold increased risk
of breast cancer compared with women whose fathers
were aged <30 years, respectively (p for trend = 0.031). In
contrast with paternal age, there was no significant trend
between maternal age at birth and risk of breast cancer in
premenopausal women (p for trend = 0.361) (Table 4).
Discussion
The results of the present study suggested that older pater-
nal age at the time of a child's birth was associated with an
increased risk of breast cancer in female offspring, which
was enhanced after controlling maternal age. The effect
appears to be stronger in premenopausal women. The
results also suggested that there was no consistent pattern
of association between maternal age at birth and risk of
breast cancer although the risk increased up to women
with mothers aged 30–34 years old and then reduced in
women with maternal age older than 35 years old.
The mean age at first full-term pregnancy was 22.0 years
old in marriage cohort before 1980 while 27.3 years old
in the cohort of 2000–2003 in Korea [29], which shows
that the age at first full-term pregnancy became progres-
sively older in younger age groups. This study also found
that the paternal and maternal age were significantly
higher in the subjects born after 1950 than in those before
1950 for both case and control groups.
The results of previous studies of the relationships of the
risk of breast cancer with paternal and maternal ages are
summarized in Table 5 and these are not consistent. Four
studies indicating that there was a increasing trend of the
Table 2: Association between paternal and maternal ages at birth and risk of breast cancer in daughters
Age at birth of the 
subjects (yrs)
Cases (%) Controls (%) OR (95% CI)1 OR (95% CI)2
Paternal age
Mean ± SD 33.1 ± 7.5 32.5 ± 7.2 1.1 (1.00–1.28)†
<30 362 (35.8) 400 (39.6) 1.0 1.0
30–34 266 (26.3) 261 (25.8) 1.2 (0.92–1.45) 1.0 (0.79–1.34)
35–39 169 (16.7) 174 (17.2) 1.1 (0.83–1.40) 1.0 (0.71–1.39)
≥40 214 (21.2) 176 (17.4) 1.4 (1.07–1.76) 1.6 (1.04–2.32)
P for trend 0.025 0.090
Maternal age
Mean ± SD 28.7 ± 6.4 28.3 ± 6.5 1.1 (0.97–1.28)†
<25 285 (28.2) 330 (32.6) 1.0 1.0
25–29 302 (29.9) 297 (29.4) 1.2 (0.97–1.54) 1.2 (0.95–1.56)
30–34 237 (23.4) 192 (19.0) 1.5 (1.18–1.95) 1.4 (1.00–1.94)
≥35 187 (18.5) 192 (19.0) 1.1 (0.88–1.48) 0.8 (0.55–1.27)
P for trend 0.079 0.998
1OR adjusted for family history of breast cancer in 1st or 2nd degree relatives and lifetime estrogen exposure duration
2OR adjusted for maternal age or paternal age (mutual parental age, categorical value) in addition to the variables in the model 1
†OR per 10 yearBMC Cancer 2005, 5:143 http://www.biomedcentral.com/1471-2407/5/143
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risk of breast cancer in women having older father, were
consisted with the present study [5,7-9]. A number of pre-
vious studies found no statistically significant association
between paternal age and the risk of breast cancer in pop-
ulation-based large scale studies. Most of negative studies
did not adjust known risk factors for breast cancer (i. e.,
family history of breast cancer in 1st and 2nd degree rela-
tives and reproductive factors). In contrast, Hodgson et al
[5] showed that there was a positive association between
breast cancer and paternal age in African-American only.
Innes et al [7] and Le Marchand et al [9] also reported a
significant linear trend in breast caner risk with paternal
age only in young cancer cases.
Most previous studies showed that maternal age was not
associated with breast cancer risk in white women. How-
ever, the finding of this study that the breast cancer risk
increased with increasing maternal age up to the interme-
diate (30–34 years old), then reduced for older than 35
years old, is consistent with previous epidemiological
studies [5,11-13,24,30]. Experimental evidences also sup-
port the association between maternal age and estrogen
level during pregnancy [31-33]. Panagiotopoulou et al
[32] showed the inverse U-shaped relationship of mater-
nal age to estrogen levels; there was a peak of estrogen lev-
els in the intermediate then there was a reduction in
estrogen levels with maternal age. This pattern that mater-
nal age was not linear relationship with estradiol level
during pregnancy and/or generally not in a dose-depend-
ent gradient with age was observed among other recent
studies [31,33]. These results supported that subjects
whose mothers were oldest at the time of birth were not
in the highest risk group in this study and it may be bio-
logically relevant because there is a perimenopausal
reduction in estrogens.
With regard to menopausal status, most previous results
between the risk of breast cancer and maternal age includ-
ing ours are inconsistent [6,7,9,22]. Potential reasons for
inconsistent association between maternal age and breast
cancer risk include differences in other maternal factors
(i.e., maternal diet, pregnancy complication, and mater-
nal reproductive history), covariates adjusted, or ethnic-
ity.
Data published so far shows that maternal and paternal
ageing may affect offspring by different mechanisms.
Higher concentration of estrogen in utero could create a
fertile soil for cancer initiation with regard to maternal age
[1]. There is some evidence that high prenatal estrogen
level affects the morphology of the mammary gland (i.e.,
the number of ductal branching, the density of terminal
end buds). An increased number of epithelial and stromal
cells offer more targets for carcinogens and greater proba-
bility for genetic/epigenetic events that affect the suscepti-
bility of the breast cancer [34]. Higher paternal age has
been implicated to be responsible for increases in chro-
mosomal aberrations and genetic disorders [35], of which
the risk increases with paternal age, but maternal age has
little or no effect on the risk after controlling for paternal
age [3]. Spermatogomia undergo continuous cell divi-
sions throughout the lifetime of the adult male, while
oocytes undergo only one cell division between puberty
and fertilization [2,3]. This difference may provide a
greater opportunity for germ cells of the father to experi-
ence errors of DNA replication in regard to delayed par-
enthood. Furthermore, the ability to respond to mutagens
with germ-cell apoptosis in order to avoid genetically
altered spermatozoa decreased with paternal age [36],
while oocytes have an efficient DNA repair system which
is independent of maternal age [37].
Although maternal and paternal ages were correlated, we
were able to ascribe the risk of breast cancer to the pater-
nal age independent on maternal age. There are, however,
several issues in the present results to consider whether
the observed effects can be due to confounding or bias.
First, potential selection bias because offspring with
higher socioeconomic status may have detected their
breast cancer earlier than those with lower socioeconomic
Table 3: OR (95% CI) of combined effect of paternal age and maternal ages on risk of breast cancer [cases/controls]
Paternal age (yrs) Maternal age (yrs)
<25 25–29 30–34 ≥35
<30 1.0
[230/273]
1.3 (0.97–1.81)
[122/116]
1.1 (0.45–2.86)
[9/10]
1.1 (0.07–17.69)
[1/1]
30–34 1.2 (0.76–1.87)
[46/47]
1.3 (0.96–1.76)
[132/127]
1.3 (0.91–1.89)
[81/79]
1.1 (0.38–2.97)
[7/8]
35–39 1.6 (0.55–4.81)
[8/6]
1.1 (0.67–1.70)
[41/46]
1.4 (1.00–2.07)
[83/74]
0.9 (0.55–1.42)
[37/48]
≥40 0.3 (0.04–3.07)
[1/4]
1.2 (0.43–3.60)
[7/8]
2.8 (1.74–4.62)
[64/29]
1.3 (0.96–1.75)
[142/135]
OR adjusted for family history of breast cancer in 1st or 2nd degree relatives and lifetime estrogen exposure durationBMC Cancer 2005, 5:143 http://www.biomedcentral.com/1471-2407/5/143
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status and because individuals with higher socioeconomic
status may tend to have children later. In this study, how-
ever, the education levels of study subjects (offspring)
were not associated with paternal or maternal ages and
education levels did not change the β coefficient of pater-
nal and maternal ages less than 15%, thus education lev-
els were not included in the final model. Moreover,
controlling for subjects' education levels in narrower cate-
gories (5 categories; at or under elementary school, at
middle school, at high school, at college, and at graduate
school) did not significantly alter the breast cancer risk of
paternal and maternal age. However, we could not adjust
parental education since we had no information about
parental education levels. Seventy-nine percent of cases
and 91% of controls came from the same catchment areas
(Seoul and suburbs). However, it did not indicate that the
subjects came from the different study bases since the hos-
pitals participated in the study were university hospitals
which covered the patients in the whole country accord-
ing to the current health delivery system in Korea [38].
Even if the catchment areas were different between cases
and controls, this difference may push the association
toward the null since more controls came from urban area
where subjects had higher education levels which was
associated with increased breast cancer risk. Second, pos-
sible unadjusting confounders from other risk factors for
breast cancer in adult life [39,40], but the risk of paternal
and maternal ages on breast cancer remained same even
after adjusting the established risk factors for breast can-
cer. However, other studies have mostly not found similar
results and since small relative risks are involved and
chance remains a likely explanation, the results of this
moderately sized case-control study should be interpreted
with extreme cautions.
Conclusion
This is the first and largest report about paternal and
maternal ages and breast cancer in Asian women. These
findings suggest that paternal age is associated with an
increased risk of breast cancer in female offspring. How-
Table 4: Association between parental ages at birth and risk of breast cancer in daughters after stratified by menopause status
Age at birth of the 
subjects (yrs)
Cases (%) Controls (%) OR (95% CI)1 OR (95% CI)2
Premenopause
Paternal age
Mean ± SD 33.7 ± 7.0 32.9 ± 6.6 1.16 (0.98–1.38)†
<30 183 (31.6) 210 (36.3) 1.0 1.0
30–34 162 (28.0) 161 (27.8) 1.1 (0.85–1.54) 1.1 (0.76–1.50)
35–39 108 (18.7) 105 (18.1) 1.1 (0.82–1.60) 1.2 (0.77–1.85)
≥40 126 (21.8) 103 (17.8) 1.4 (1.00–1.93) 1.9 (1.12–3.26)
P for trend 0.062 0.031
Maternal age
Mean ± SD 29.1 ± 5.8 28.8 ± 6.1 1.06 (0.87–1.29)†
<25 133 (23.0) 159 (27.5) 1.0 1.0
25–29 194 (33.5) 187 (32.3) 1.3 (0.93–1.73) 1.2 (0.86–1.70)
30–34 147 (25.4) 120 (20.7) 1.5 (1.06–2.07) 1.2 (0.78–1.88)
≥35 105 (18.1) 113 (19.5) 1.1 (0.76–1.55) 0.7 (0.38–1.15)
P for trend 0.363 0.361
Postmenopause
Paternal age
Mean ± SD 32.2 ± 8.1 31.8 ± 8.0 1.11 (0.94–1.32)†
<30 179 (41.4) 190 (44.0) 1.0 1.0
30–34 104 (24.1) 100 (23.2) 1.2 (0.82–1.65) 1.0 (0.66–1.48)
35–39 61 (14.1) 69 (16.0) 1.0 (0.65–1.49) 0.8 (0.47–1.35)
≥40 88 (20.4) 73 (16.9) 1.4 (0.94–2.03) 1.2 (0.66–2.29)
P for trend 0.173 0.804
Maternal age
Mean ± SD 28.2 ± 7.1 27.7 ± 6.9 1.16 (0.95–1.41)†
<25 152 (35.2) 171 (39.6) 1.0 1.0
25–29 108 (25.0) 110 (25.5) 1.1 (0.80–1.60) 1.2 (0.80–2.29)
30–34 90 (20.8) 72 (16.7) 1.6 (1.05–2.31) 1.6 (0.97–2.69)
≥35 82 (19.0) 79 (18.3) 1.2 (0.82–1.78) 1.1 (0.58–2.03)
P for trend 0.112 0.415
1OR adjusted for family history of breast cancer in 1st or 2nd degree relatives and lifetime estrogen exposure duration
2OR adjusted for maternal age or paternal age (mutual parental age, categorical value) in addition to the variables in the model 1
†OR per 10 yearB
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Table 5: Summary of results from previous studies of parental ages and breast cancer development
Study Country N (# cases) Age (yrs) Paternal age 
(PA)
RR Maternal age 
(MA)
RR Adjusting Restricted
Mutually* Covariates†
Cohort study
Colditz et al, 1991 US 118,309 (1,976) 3055 ≥39 vs. <20 0.9 (0.56–1.45) ≥39 vs. <20 0.9 (0.57–1.39) YES YES -
Zhang et al, 1995 US 2,662 (149) 29–62 ≥36 vs. <29 0.8 (0.5–1.4) 26–31 vs. <26 1.5 (1.0–2.4) - YES -
Holmberg et al1, 1995 US 384,769 (1,967) - ≥45 vs. <20 0.8 (0.48–1.28) ≥45 vs. <20 1.3 (0.85–1.98) - YES -
Hemminki et al, 1999 Sweden 3,800,000 
(8,877)
15–53 40–49 vs. <25 1.1 (0.94–1.18) 40–49 vs. <20 1.1 (0.91–1.27) YES - PA in sporadic 
cases
Hilakivi-Clarke et al, 2001 Finland 3,447 (177) - - - - NS - - -
Study Country Cases/controls Age (yrs) Paternal age (PA) OR Maternal age 
(MA)
OR Adjusting Remark
Mutually* Covariates†
Case-control study
Standfast et al, 1967 US 229/229 40–44 - - 29.1 vs. 28.2 2p < 0.05 - - -
Henderson et al, 1974 US 308/308 <64 31.5 vs. 30.7 NS 27.3 vs. 26.3 P < 0.01 - - -
Rothman et al, 1980 International 4339/12760 - - - 35–39 vs. <20 1.30 - YES -
Baron et al, 1984 UK 971/971 ≤50 - - 21–25 vs. ≤20 1.4 (0.92–2.18) - YES -
Le Marchand et al, 1988 US 153/461 <45 36–59 vs. 19–26 1.4 (0.81–2.41) 30–46 vs. 23–26 1.7 (0.99–2.78) - - Pts <33 yrs
Janerich et al, 1989 US 801/2647 - Per 10-yrs 1.2 (1.07–1.33) Each 10-yrs 1.2 (1.09–1.41) - - -
Thompson et al, 1990 US 2492/2687 20–54 - - 35–39 vs. <20 1.5 (1.10–1.93) - YES parous
Hsieh et al, 1991 International 927/2616 ≥35 - - Each 5-yrs 1.1 (1.01–1.10) - YES postmenopause
Ekbom et al, 1992 Sweden 458/1197 ≥35 - - Each 5-yrs 1.0 (0.92–1.12) - - -
Janerich et al, 1994 US 2414/9138 - ≥45 vs. <25 1.0 (0.76–1.28) ≥40 vs. <20 1.1 (0.87–1.37) - YES -
Sanderson et al, 1995 US 1147/1399 21–45, 50–64 - - ≥35 vs. <25 1.0 (0.7–1.4), 1.0 
(0.7–1.5)
-- -
Ekbom et al, 1997 Sweden 1068/2727 - - - Each 5-yrs 1.1 (0.99–1.14) - - -
Newcomb et al, 1997 US 1253/1121 - ≥40 vs. ≤24 0.9 (0.68–1.24) ≥40 vs. ≤20 0.9 (0.62–1.37) - YES -
Weiss et al, 1997 US 2173/1990 20–55 - - ≥35 vs. <20 0.9 (0.7–1.3) - YES -
Innes et al, 2000 US 484/2870 14–37 ≥40 vs. 25–29 1.5 (1.03–2.23) ≥35 vs. 20–24 1.9 (1.18–3.18) YES - -
Titus-Ernstoff et al, 2002 US 5629/5928 50–79 - - ≥40 vs. 25–29 1.3 (0.90–1.79) - - postmenopause
Mellemkjr et al, 2003 Denmark 881/3423 <40 - - ≥30 vs. <25 1.1 (0.90–1.36) - - -
Hodgson et al, 2004 US 280/236 18–74 35–56 vs. 23–27 1.5 (0.7–3.2) ≥23–27 vs. 19–
22
3.5 (2.0–5.9) YES - PA in African 
American
* Adjusted for mutually parental age; †Adjusted for other risk factors of breast cancer risk including family history of breast cancer in 1st or 2nd degree relatives and reproductive history; 
1Mortality of breast cancer, relative hazard; 2Paired t testBMC Cancer 2005, 5:143 http://www.biomedcentral.com/1471-2407/5/143
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ever, further prospective study is needed to verify the
present findings.
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